Dan Gray

Dan Gray, CFA has a diverse work experience spanning different industries and roles. Dan began their career at Ford Motor Company, where they specialized in long-term funding and securitization from 2010 to 2013. Dan then moved on to The ADT Corporation as a capital markets professional in 2013. In 2014, they joined Boston Consulting Group (BCG) as a strategy consultant. Dan later transitioned to Santander Consumer USA, where they worked in capital markets from 2015 to 2017. Dan then joined Bain & Company in 2017 as a Manager/CTL, focusing on strategy consulting until 2020. Dan further advanced their career at DaVita Kidney Care as a Director of Strategy from 2020 until September 2023. Dan'smost recent role is as the Senior Enterprise Strategy Director at US Pharmacopeia, which commenced in September 2023. Throughout their career, Dan Gray has consistently demonstrated their expertise in strategy and capital markets.

Dan Gray, CFA holds a Master of Business Administration (MBA) degree with a concentration in Finance from The Ohio State University Fisher College of Business. Dan is also a Chartered Financial Analyst (CFA) Charterholder, certified by the CFA Institute.